The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients

BACKGROUND: Recent randomized trials have not found that polymyxin B hemoperfusion (PMX-HP) improves outcomes for patients with sepsis. However, it remains unclear whether the therapy could provide benefit for highly selected patients. Monocyte human leukocyte antigen (mHLA-DR) expression, a critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Srisawat, Nattachai, Tungsanga, Somkanya, Lumlertgul, Nuttha, Komaenthammasophon, Chalermchai, Peerapornratana, Sadudee, Thamrongsat, Nicha, Tiranathanagul, Khajohn, Praditpornsilpa, Kearkiat, Eiam-Ong, Somchai, Tungsanga, Kriang, Kellum, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204024/
https://www.ncbi.nlm.nih.gov/pubmed/30367647
http://dx.doi.org/10.1186/s13054-018-2077-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204024/
https://www.ncbi.nlm.nih.gov/pubmed/30367647
http://dx.doi.org/10.1186/s13054-018-2077-y

Ejemplares similares